Evidence map›Paper›PMID 41474341›Full record

ArticleAntimicrobial agents and chemotherapy2026

Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain.

Joaquín Llorente, Julio Sempere, Mirella Llamosí, Covadonga Pérez-García, Aída Úbeda, Erick Joan Vidal-Alcántara, Juan Carlos Sanz, Mirian Domenech, Jose Yuste

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Antibacterial and Antibiofilm Activity ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Change in the distribution ofFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joaquín Llorente *Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Julio Sempere *Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Mirella LlamosíSpanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Covadonga Pérez-GarcíaSpanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Aída ÚbedaSpanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Erick Joan Vidal-AlcántaraSpanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Juan Carlos SanzRegional Public Health Laboratory, Comunidad de Madrid, Madrid, Spain.
Mirian DomenechSpanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0002-0942-8180
Jose YusteSpanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0001-7996-0837

Funding

Instituto de Salud Carlos III PI24CIII/00045Merck Sharp and Dohme United Kingdom MISP#IISP60170Spanish National Plan for Scientific and Technical Research and Innovation PID2024-161570OB-I00
6 · The paper itself

Abstract

Pneumococcal conjugate vaccines (PCVs) have significantly reduced disease burden caused by

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialPneumococcal InfectionsStreptococcus pneumoniaeChildChild, PreschoolCOVID-19ErythromycinFemaleHumansInfantMaleMicrobial Sensitivity TestsPenicillinsPneumococcal VaccinesSARS-CoV-213-valent pneumococcal vaccineAnti-Bacterial AgentsErythromycinPenicillinsPneumococcal Vaccinesinvasive pneumococcal diseasespneumococcal conjugated vaccineresistant antibioticsserotype replacement

Identifiers

PMID41474341
PMCPMC12888898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.